Source: EIN Presswire

Press Release: Tx3 : Tx3 Services and Apexon Form Strategic Life Sciences Partnership - DELETED

Tx3 Services and Apexon combine their experience, solutions, and Life Sciences practices to service FDA regulated organizations. DOYLESTOWN, PA, UNITED STATES, September 14, 2021 /⁨EINPresswire.com⁩/ -- In a continued effort to expand digital technology ...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jason Tepfenhardt's photo - Co-Founder & CEO of Tx3

Co-Founder & CEO

Jason Tepfenhardt

CEO Approval Rating

87/100

Read more